-+ 0.00%
-+ 0.00%
-+ 0.00%

SAGIMET BIOSCIENCES ANNOUNCES FIRST PATIENT DOSED IN AURORA PHASE 3 U.S. CLINICAL TRIAL OF DENIFANSTAT FOR MODERATE TO SEVERE ACNE

Reuters·10/22/2026 11:05:48